Vulnerability to depression and cardiometabolic risk associated with early ovarian disruption

Menopause

Volumn 20, Issue 6, 2013, Pages 598-599

  Clayton, Anita H ^a   Pinkerton, Joann V ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CONTRACEPTIVE AGENT; HIGH DENSITY LIPOPROTEIN; NEUROTRANSMITTER; SEX HORMONE;

CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLIMACTERIUM; DEPRESSION; DISEASE ASSOCIATION; EDITORIAL; HUMAN; ISCHEMIC HEART DISEASE; MENSTRUAL CYCLE; MIGRAINE; MOOD CHANGE; OBESITY; OVARY DISEASE; OVARY FUNCTION; OXIDATIVE STRESS; SEXUAL DYSFUNCTION; VASOMOTOR DISORDER;

CARDIOVASCULAR DISEASES; DEPRESSION; FEMALE; HUMANS; METABOLIC SYNDROME X; OVARY; PREMENOPAUSE;

EID: 84879171695     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e3182932cca     Document Type: Editorial

References (12)

1. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006;63:375-382.
2. Cohen LS, Soares CN, Vitonis AF, et al. Risk for new onset of depression during the menopausal transition: The Harvard Study of Moods and Cycles. Arch Gen Psychiatry 2006;63:385-390.
3. Bromberger JT, Matthews KA, Schott LL, et al. Depressive symptoms during the menopausal transition: The Study of Women's Health Across the Nation (SWAN). J Affect Disord 2007;103:267-272.
4. Woods NF, Smith-DiJulio K, Percival DB, Tao EY, Mariella A, Mitchell S. Depressed mood during the menopausal transition and early postmenopause: Observations from the Seattle Midlife Women's Health Study. Menopause 2008;15:223-232.
5. Bleil ME, Bromberger JT, Latham MD, et al. Disruptions in ovarian function are related to depression and cardiometabolic risk during premenopause. Menopause 2013;20:631-639.
6. Baune BT, Stuart M, Gilmour A, et al. Moderators of the relationship between depression and cardiovascular disorders: A systematic review. Gen Hosp Psychiatry 2012;34:478-492.
7. Modgill G, Jette N, Wang JL, et al. A population-based longitudinal community study of major depression and migraine. Headache 2012;52: 422-432.
8. Atlantis E, Sullivan T. Bidirectional association between depression and sexual dysfunction: A systematic review and meta-analysis. J Sex Med 2012;9:1497-1507.
9. Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity and depression: A systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2012;67:220-229.
10. Ye S, Muntner P, Shimbo D, et al. Behavioral mechanisms, elevated depressive symptoms, and the risk for myocardial infarction or death in individuals with coronary heart disease. J Am Coll Cardiol; 61: 622-630.
11. Ramasubbu R, Taylor VH, Samaan Z, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions. Ann Clin Psychiatry 2012;24:91-109.
12. Freeman EW. Associations of depression with the transition to menopause. Menopause 2010;17:823-827.